Interferon signaling, systemic inflammation, and atherosclerosis following welding fume inhalation exposure: from the lung to the blood to the vasculature
Public Domain
-
2011/03/01
-
Details
-
Personal Author:Antonini JM ; Chen BT ; Erdely A ; Frazer DG ; Hulderman T ; Kashon ML ; Li S ; Liston AL ; Salmen-Muniz R ; Simeonova PP ; Stone S ; Zeidler-Erdely PC
-
Description:Inhalation of particulates can result in measurable systemic markers related to adverse cardiovascular outcomes. Our aim was the determination of a systemic signature and atherosclerosis progression following gas metal arc-stainless steel (GMASS) welding fume exposure. C57BL/6 mice were exposed for 10d to GMA-SS by inhalation (40mg/m3 for 3hr/day) and harvested 4hr, 14d and 28d post-exposure. Systemic responses were measured by serum protein profiling and microarray (Ingenuity pathway analysis and real-time RT-PCR confirmation) for whole blood cells, aorta and lung. Atherosclerotic susceptible apolipoprotein E knockout (apoE- /-) mice were exposed (40mg/m3 for 3hr/day) during week 6 and 7 of two months of Western (high fat) diet feeding. Exposed C57BL/6 mice exhibited a specific network of type I interferon signaling in blood cells and aorta from 4hr to 28d post-exposure The central component of the network was the transcription factor interferon regulatory factor 7 (Irf7), the master regulator of the type I interferon response. Increases in related genes (Oasl2 and Ifitm3) were also validated. Type I interferon signaling was also a top network in the lung supporting the concept of a systemic signature reflecting the ongoing pulmonary response. Serum levels of primary inflammatory mediators were not elevated although oncostatin M, an IL-6 family cytokine and type I interferon enhancer, was increased. In apoE-/- mice, pulmonary inflammation, serum levels of IL-1â and MAC-3 and blood cell expression of Irf7 were increased post-GMA-SS exposure. Atherosclerosis severity, determined by plaque area and intensity in the aorta (en face), was increased. The data suggest an immunomodulatory and mild systemic inflammatory effect with increased progression of atherosclerosis due to GMA-SS exposure. Most notably, a pulmonary and corresponding systemic signature of type I interferon signaling was consistently evident across tissue and time. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:1096-6080
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Pages in Document:39
-
Volume:120
-
NIOSHTIC Number:nn:20038426
-
Citation:Toxicologist 2011 Mar; 120(Suppl 2):39
-
Federal Fiscal Year:2011
-
Peer Reviewed:False
-
Source Full Name:The Toxicologist. Society of Toxicology 50th Annual Meeting and ToxExpo, March 6-10, 2011, Washington, DC
-
Supplement:2
-
Collection(s):
-
Main Document Checksum:urn:sha-512:544e87b3593be13d18e99193c4d3bd3161c2d5d04d9f58b408c3b48e66dbc45f8ac0b815b891e6b4f02aa351e32f0f65d93dbbd4f975cb45a7c4a131440c2999
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like